683 global research publications on Terminalia arjuna were derived from the Scopus database during the last 22 years (1997-18) with a view to study its quantitative and qualitative aspects. The global publication data showed that the average annual and eleven-year cumulative global output of Terminalia arjuna research registered 8.33% and 169.19% growth. The plant global citation impact averaged to 16.92 citations per paper (CPP) in twenty-two years, which decreased from 36.02 CPP to 9.82 CPP from 1997-07 to 2008-18. The top 10 most productive countries together accounted for more than 100.0% global publication share and 99.13% global citation share during 1997-18. India, alone accounting for the highest and largest publication share of 82.43% and other 9 countries from 1.02% to 5.27% during 1997-18. Five out of top 10 countries, namely Iran (2.85), U.K. (1.94), Japan (1.22), USA (1.16) and Pakistan (1.09) registered relative citation index above the global average of 0.97. Pharmacology, toxicology and pharmaceutics, among seven broad subjects, contributed the largest publications share of 50.51%, followed by medicine (30.31%), biochemistry, genetics and molecular biology (26.52%), agricultural and biological sciences (21.52%) and other 3 sub-fields contribution varying from 4.54% to 10.83% during 1997-18. 239 global organizations and 309 global authors in global Terminalia arjuna research during 1997-18, of which the 15 most productive global organizations and authors together contributed 30.16% and 15.37% global publication share and 36.87% and 20.68% global citation share respectively during 1997-18. Hamdard University, Delhi, India (with 30 papers), Banaras Hindu University, Varanasi, India (22 papers) and All India Institute of Medical Sciences, New Delhi, India (19 papers), S. Dwivedi (with 11 papers), S.K. Maulik (10 papers) and P.C. Sil (8 papers) and Journal of Ethno pharmacology (with 26 papers), International Journal of Pharmacy and Pharmaceutical Sciences (15 papers), Asian Journal of Pharmaceutical and Clinical Research (14 papers) were the three leading organizations, authors and journals reporting global research in Terminalia Arjuna during 1997-18.